Residual lesions in postoperative pediatric cardiac surgery patients receiving extracorporeal membrane oxygenation support Hemant S. Agarwal, MBBS, FAAP, Daphne C. Hardison, VPNPP, Benjamin R. Saville, PhD, Brian S. Donahue, MD, PhD, Fred S. Lamb, MD, PhD, David P. Bichell, MD, Zena L. Harris, MD The Journal of Thoracic and Cardiovascular Surgery Volume 147, Issue 1, Pages 434-441 (January 2014) DOI: 10.1016/j.jtcvs.2013.03.021 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 Outcome of postoperative pediatric cardiac surgery patients placed on extracorporeal membrane oxygenation (ECMO). In group A, early detection (≤3 days of ECMO duration) of residual lesions in postoperative pediatric cardiac surgery patients placed on ECMO is noted. In group B, late detection (>3 days of ECMO duration) of residual lesions in postoperative pediatric cardiac surgery patients placed on ECMO is noted. Patients not suspected of having residual lesions are indicated in group C. The Journal of Thoracic and Cardiovascular Surgery 2014 147, 434-441DOI: (10.1016/j.jtcvs.2013.03.021) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions